The FDA has rejected data submitted by Amylin Pharmaceuticals for a longer-acting Byetta, which will likely delay the new version of their diabetes drug. This is another blow to Amylin, which has seen their stock price plummet this year after Byetta was linked to fatal pancreatitis cases in August. Continued
All Posts Tagged With: "Diabetes"
Avandia Heart Risks Cause Diabetes Associations to Recommend Against Using the Drug
As a result of serious concerns about the side effects of Avandia, which include an increased risk of heart attacks, congestive heart failure and other serious injuries, the American Diabetes Association and the European Association for the Study of Diabetes have dropped the drug from their consensus statement on type 2 diabetes treatments, unanimously advising against use of the drug. Continued
BPA Plastic Bottle Chemical Linked to Risk of Diabetes, Heart Disease, Liver Problems
Data presented to an FDA panel of outside experts on Tuesday links exposure to the plastic bottle chemical bisphenol A, also known as BPA, to an increased risk of diabetes, heart disease and liver problems in humans. Continued
Zyprexa Class Action Lawsuit Certified
On Friday, a federal judge certified a Zyprexa class action lawsuit for a group of “third party payors” who allege that Eli Lilly committed fraud by selling their anti-psychotic drug at high prices, while exaggerating its benefits and understating the Zyprexa side effects. Continued
Seroquel Lawsuit
The use of the antipsychotic medication Seroquel has been linked to an increased risk of diabetes, pancreatitis and death. Thousands of Seroquel lawsuits have been filed throughout the United States by individuals who suffered severe and life threatening injuries. Continued
Byetta Lawsuit Filed For Pancreatitis
A diabetic patient who developed pancreatitis as a side effect of Byetta has filed a lawsuit in a California state court. This is reportedly the first Byetta lawsuit to be filed in the United States involving pancreatitis. Continued
Rapamune (sirolimus) Lawsuits
Recent research suggests that Rapamune, also known as sirolimus, may increase the risk of diabetes after a kidney transplant. This is a serious health concern, and could lead to kidney transplant failure. Continued
